Webinar: Analyzing vaccine purity – without an HCP ELISA

13 June 2022

Is your viral vaccine pure and consistent?

One of the biggest challenges in developing viral vaccines is ensuring and documenting that the downstream process consistently produces a safe product – with low Host Cell Proteins (HCPs) levels.

Join Ejvind Mortz on June 29:

Learn how one LC-MS assay identifies and quantifies all proteins in the product – irrespective of the protein source.

Learn more about his webinar and sign up here >>